| 证券代码 | ELOS.O |
| 证券名称 | 赛诺龙 |
| 证券类型 | 美股 |
| 上市场所 | 纳斯达克交易所 |
| 上市板块 | 主板 |
| 发行方式 | 公开发售 |
| 首发上市日 | 2004-08-06 |
| 首发价格(元) | 12 USD |
| 首发数量(股) | 5000000 |
| 首发募资额(元) | 60,000,000.00 USD |
| 首发主承销商 | Citigroup Global Markets Inc |
| 货币单位 | USD |
| 公司名称 | Syneron Medical Ltd. |
| 注册地址 | 以色列 |
| 办公地址 | Industrial Zone, Yokneam Illit, Tavor Building P.O.B. 550, Israel |
| 成立日期 | 2000-07 |
| 董事会主席 | Shimon Eckhouse |
| 公司属地 | Israel 以色列 |
| 公司网址 | www.syneron-candela.com |
| 电话 | +972 (73) 244-2200 |
| 传真 | +972 (73) 244-2202 |
| 公司简介 | Syneron Medical Ltd. which is both the parent company and an operating company, is principally engaged in the manufacture, research, development, marketing and sales worldwide, directly to end-users and also to distributors, of advanced equipment for the aesthetic medical industry and systems for dermatologists, plastic surgeons and other qualified practitioners. Its products consist principally of professional aesthetic devices. Its revenues are comprised of product sales, product-related services, and consumables. These services and consumables comprise its recurring revenue model. Its recurring revenue model is based on the sale of consumables, mainly associated with its growth engine platforms, including UltraShape Power, Profound, CO2RE Intima, and PicoWay brand names, and patient treatment fees. It has a number of new projects and products under development, focusing mainly on additional non-invasive aesthetic treatments, which will have recurring revenue and consumables components. |